Hjem › Kronisk inflammatorisk demyeliniserende polyradikuloneuropati › Michigan
Kronisk inflammatorisk demyeliniserende polyradikuloneuropati kliniske forsøg i Michigan
5 studier for Kronisk inflammatorisk demyeliniserende polyradikuloneuropati søger deltagere på steder i Michigan.
Officiel studietekst (engelsk)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Site Number - 1629, Detroit
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07032662A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- University of Michigan Hospital, Ann Arbor
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Henry Ford Hospital- Site Number : 8400025, Detroit
- Michigan State University- Site Number : 8400038, East Lansing
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT06290141A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06680037A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Clinical Study Site, East Lansing
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT06858579Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.